Our use of cookies
We would like to use necessary cookies to perform the basic functions of this website. Such strictly necessary cookies do not require your consent and are therefore always active. We would also like to set analytical cookies and advertising cookies that help us make improvements by measuring how you use our website. Both the analytical cookies and advertising cookies require your consent and are therefore called “optional cookies”. Detailed information about the use of cookies and how you can control your consent for optional cookies can be found in our Cookie Policy and Privacy Policy.

Hello! We use cookies to help improve your experience of our website. With your consent, statistical and analytical cookies may also be used on this website. If you agree to the use of these additional cookies, please mark your choice:
cfDNA and Sequencing, a “one-two punch” to knock out cancer at Round 1
Explore the role of cell-free DNA (cfDNA) in early cancer detection and how integrative modeling of tumor genomes and epigenomes enhances prognosis. Learn about the superior performance of MGI data and the future of cfDNA-based cancer diagnosis.

MGI Virtual Xpert: Mastering the MGISP-100
With this episode, unlock the full potential of your high-throughput sequencing endeavours with the MGISP-100 Automated Sample Preparation System.

MGI Virtual Xpert: Embrace the Future of Life Science Research with MGISP-960
With this episode, discover unparalleled efficiency and precision with the MGISP-960 High-throughput Automated Sample Preparation System.

MGI Virtual Xpert: Introduction to DNBSEQ-G400: Comprehensive and Flexible Genome Sequencer
With this episode, learn about the most flexible high-performance genome sequencers at MGI: Our DNBSEQ-G400

MGI Virtual Xpert: Introduction to DNBSEQ-G50: Compact and flexible benchtop sequencer
With this episode, learn about compact & flexible DNBSEQ-G50 Genetic Sequencer

A Complete Human Y to ask more "Why" in biology
Unlock the mysteries of the human Y chromosome with MGI's cutting-edge findings. Learn how the T2T consortium's study corrects GRCh38 errors, reveals 30Mb+ new sequence data, and advances our understanding of gene structures and their implications in the Omic-verse.

Can Next-generation Sequencing accelerate mRNA vaccine development?
Explore the transformative impact of Next-Generation Sequencing in mRNA vaccine development. Dive into Nobel-winning discoveries, challenges, and novel technologies like the VAX-seq workflow, enhancing vaccine production, safety, and quality analysis amidst global health crises.

Single-cell Spatial transcriptomics (sc-StereoSeq), opening a new era in plants and crops biology.
Explore how sc-StereoSeq is transforming our understanding of plant biology, from crop production to plant stress responses, marking a new era in spatial transcriptomics.

Smart-seq3Xpress: a scalable, high-sensitivity and low-cost Single cell Full-length RNA-seq methodology.
Revolutionizing single-cell RNA-seq, SMART-seq3Xpress offers unparalleled sensitivity and cost-efficiency with full-length coverage.

When Genomics meets Metabolomics by Circulating Metabolites in Blood
This piece delves into how genetic variations impact metabolic processes, offering new angles on tackling metabolic diseases. A must-read for insights into the future of personalized healthcare.

Pooling of Microbiological Samples with ABL Diagnostics' DeepCheck® Assays & Software and MGI's DNBSEQ-G400
Pooling of Microbiological Samples with ABL Diagnostic's DeepChek® and MGI's DNBSEQ-G400: Leverage DeepChek® assays and the DNBSEQ-G400 for high-throughput, cost-effective microbial analysis.

New Strain of Mpox Emerges: MGI Tech’s Pathogen Sequencing Solutions at the Forefront
The WHO declared the mpox outbreak a "Public Health Emergency of International Concern" due to its rapid spread, while MGI's advanced sequencing tools are crucial in identifying and controlling the virus worldwide

MGI Announces Commercial Launch of HotMPS High-Throughput Sequencing Kit* and Instrument** in Germany
"We are delighted to be bringing our proven DNBSEQ™ technology to customers and partners in Germany once again," said Dr. Yong Hou.

Release date: 25.02.2023

MGI Partners with ALACRiS Theranostics to Open New Customer Experience Center in Germany
Unveiling MGI's Customer Experience Center in Berlin: Empowering Precision Medicine. Explore MGI's new Customer Experience Center in Berlin, Germany, fostering precision medicine through innovative automation and sequencing. Revolutionize cancer diagnostics, personalized oncology services, and cutting-edge technologies.

Release date: 02.01.2023

ICG-17
The 17th Annual Meeting of the International Conference on Genomics (ICG-17) was held on-site and online in Riga, Latvia (OMICS Advances in Africa and Europe, September 7-9).

event 07.09 - 09.09.2022

Riga, Latvia

MGI Empowers European Genomics with the Launch of MGISP-Smart 8 and Empowerment Program at MEDICA
Celebrating the MGISP-Smart 8's European launch and our Empowerment Program at MEDICA, MGI continues to pioneer genomics research through steadfast innovation.

Release date: 08.03.2023

Düsseldorf, Germany

Revolutionizing Genomics: How MGI Spurs Healthy Market Competition, Insights from GNOMIX's Chief Scientist
GNOMIX, a global genetics lab renowned for its diverse services, embraces MGI's role in stimulating market competition and shaping the genomics sector.

Release date: 16.04.2023

Transforming Pig Breeding: Revolutionizing China's Pig Breeding Industry
Pig Breeding Revolution: Prof. Zhao Shuhong and team at Huazhong Agricultural University are reshaping China's industry with groundbreaking genomics research. Explore the future of pig breeding.

Release date: 24.06.2022

User Voice | Turkish Genetic Disease Diagnosis Center: MGI’s sequencing technology and platform can provide us with more stable and accurate data results
NGC, a top genetic disease diagnosis center in Turkey, utilizes MGI's sequencing technology and platform for stable and accurate data results in their high-quality genetic testing services.

Release date: 30.11.2022

Accelerated and Enhanced Virus Sequencing Achieved at Latvian Biomedical Research Center using the MGI Sequencing Platform
Latvian Biomedical Research Center Uses MGI's Sequencing Platform for Faster and More Efficient Virus Sequencing in the Fight against the Global Pandemic.

Release date: 16.02.2023

Breakthroughs in Agrigenomics: MGI Revolutionizes Molecular Breeding
MGI Revolutionizes Agrigenomics Research and Molecular Breeding with Advanced Sequencing Technology and Platforms. Discover the Future of Agriculture with MGI's Innovations.

Release date: 30.09.2022

MGI's DNBSEQ-T20×2* Wins BEYOND Healthcare Innovation Award
MGI's award-winning DNBSEQ-T20×2* gene sequencing platform revolutionizes DNA sequencing in healthcare, offering unparalleled throughput and cost-efficiency for researchers and clinicians.

Release date: 12.05.2023

MGI Launches Overseas Production Line of DNBSEQ-G400* Sequencer in Latvia
MGI Tech Co., Ltd. launches an overseas production line in Latvia to assemble the advanced DNBSEQ-G400* gene sequencing instruments and HotMPS** reagents, marking a significant milestone in MGI's expansion into the European market.

Release date: 08.05.2023

Riga, Latvia, MGI

MGI's DNBSEQ-T20*x2 Wins 2023 Globee® Awards for Medical Equipment
Explore MGI's latest achievement as its DNBSEQ-T20×2 gene sequencing platform wins the prestigious Globee® for Medical Equipment in the 15th Annual 2023 Golden Bridge Business and Innovation Awards®. This post highlights MGI's commitment to innovation in the life science industry, their groundbreaking T20 gene sequencer, and how their technology is reshaping healthcare outcomes and the genetic industry.

Release date: 10.07.2023